Challenges in Treatment and the Importance of Radiotherapy in a Synchronous Endometrial and Breast Cancer

Gaube, Alexandra; Michire, A.; Văcăroiu, Ileana Adela; Balcangiu-Stroescu, Andra; Georgescu, D.E.; Georgescu, M.T.; Tulin, Raluca; Călinoiu, Amalia Loredana

doi:10.2478/inmed-2022-0232

Abstract

We report the case of a 69-year-old-female with synchronous endometrial and breast cancer. The imaging and pathology results confirmed the diagnosis. The patient underwent surgery and chemotherapy for endometrial cancer, and surgery followed by external beam radiotherapy for breast cancer. The patient’s clinical condition and imaging showed a favorable evolution after 2 months of follow-up.

References

1. Michael MB, Erika OW, Robert JG. Diagnosis and Management of Endometrial Cancer. Fam Physician. 2016 Mar 15;93(6):468-74.
Search in Google Scholar Back to article
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer Incidence and Mortality Worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015 Mar 1;136(5 ): E359-86. https://doi:10.100injc.2921010.1002/ijc.2921025220842
Search in Google Scholar Back to article
3. Andrew MG, James A.L.B, Michael JK. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastatic Rev. 2015; 34(1): 145155.- Published online 2015 Feb 27. https://doi:10.1007/s10555-015-9551-7
Search in Google Scholar Back to article
4. Romaszko-Wojtowicz A, Buciñski A, Doboszyñska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clinical and Experimental Medicine. 2018 Aug;18(3):391-397. https://doi:10.1007/s10238-018-0498-1.10.1007/s10238-018-0498-129550986
Search in Google Scholar Back to article
5. Jenny N, Toshima ZP, Khalil H, Elisabeth KS, Zakaria E, Per K, Salmir N, and Aniko K. Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018. Breast Cancer Res Treat. 2020 Nov.; 184(1): 221228. https://doi:10.1007/s10549-020-05822-z10.1007/s10549-020-05822-z756870932740808
Search in Google Scholar Back to article
6. Mehmet SC, Suresh M. Multiple Primary Tumors over a lifetime. Oncology (Williston Park). 2019 Jul 16;33(7): 629384
Search in Google Scholar Back to article
7. Pariyada T, Bhoom S, Nurchavadee V, Panudeth J, Benjarat T, Cholticha V, Suwanit T, Somsri L, and Vitton C. Risks and cancer associations of metachronous and synchronous multiple primary cancers. BMC Cancer. 2021 Sep 23; 21(1): 1045. https://doi:10.1186/s12885-021-08766-910.1186/s12885-021-08766-9846196934556087
Search in Google Scholar Back to article
8. Chang-Ching Y, Peng-Hui W, Chiung-Ru L, Min-Shyen Y, Kuan-Cjong CF. Synchronous breast invasive ductal carcinoma and endometrial endometrioid adenocarcinoma: A case report. J Obstet Gynaecol Res. 2011 Sep; 37(9):1246-9. https://doi.org/10.1111/j.1447-0756.2010.01502.x10.1111/j.1447-0756.2010.01502.x21518130
Search in Google Scholar Back to article
9. Lv M, Zhang X, Shen Y, Wang F, Yang J, Chen Z, Li P, Zhang X, Li S, Yang J. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore). 2017 Apr;96 (17):e6799. https://doi:10.1097/MD.000000000000679910.1097/MD.0000000000006799541328628445321
Search in Google Scholar Back to article
10. Ali AT. Risk factors for endometrial cancer. Ceska Gynekologie. 2013 nov; 78(5):448-459
Search in Google Scholar Back to article
11. Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Prevention of Breast Cancer. International Journal of Biological Sciences. 2017; 13(11): 13871397. https://doi:10.7150/ijbs.2163510.7150/ijbs.21635571552229209143
Search in Google Scholar Back to article
12. Adel E.B. MDCT evaluation of synchronous breast carcinoma and other solid malignancies. Breast Disease. 2021;40(4):275-281. https://doi:10.3233/BD-20106510.3233/BD-20106534120894
Search in Google Scholar Back to article
13. Matthias M and Rosemarie F. MRI of endometrium cancer how we do it. Cancer Imaging. 2016 May 9;16:11. https://doi:10.1186/s40644-016-0069-110.1186/s40644-016-0069-1486077127157039
Search in Google Scholar Back to article
14. Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee Si. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 Apr; 287(1): 176184. https://doi:10.1148/radiol.201717096310.1148/radiol.2017170963588163929185901
Search in Google Scholar Back to article
15. Bruzonne M, Miglietta L, Franzone P, Gadducci A, Boccardo F. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients-Author links open overlay panel. Gynecologic Oncology. 2004 May; 93(2):345-52. https://doi.org/10.1016/j.ygyno.2004.02.00810.1016/j.ygyno.2004.02.00815099944
Search in Google Scholar Back to article
16. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Prognostic factor and patterns of recurrence. Cancer. 1993 June 1;71(11):3697-702. https://doi:10.1002/1097-0142(19930601)71:11---lt---3697::aid-cncr2820711137---gt---3.0.co;2-u.10.1002/1097-0142(19930601)71:11<;3697::AID-CNCR2820711137>3.0.CO;2-U
Search in Google Scholar Back to article
17. Georgescu MT, Georgescu DE, Georgescu TF, Serbanescu GL. Changing the prognosis of metastatic cervix uteri adenosquamous carcinoma through multimodal approach: a case report. Case reports in Oncology. 2020 Sep-Dec; 13(3): 1545-1551. https://doi:10.1159/00051156410.1159/000511564784173733564296
Search in Google Scholar Back to article
18. Georgescu MT, Moldoveanu VG, Ileanu BV, Anghel R. Dosimetric influence of uterus position in cervix cancer high-dose-rate brachytherapy. Romanian Journal in Physics. 2016 Vol. 61, Nos. 910, P. 15571566.
Search in Google Scholar Back to article
19. Georgescu MT, Anghel R. Variation in uterus position prior to brachytherapy of cervix: A case report. Journal of Medicine and Life. 2017 Jan-Mar; 10(1): 9093.
Search in Google Scholar Back to article
20. Shu-Lian W, Hui F, Yong-Wen S, Wei-Hu W, Chen H, Yue- Ping L, Jing J, Xin-Fan L, Zi-hao Y, Hua R, Ning L, Ning-Ning L, Yu T, Yuan Y, Shu-Nan Q, Guang-yi S, Ran P, Shuai L, Bo C, Yong Y, Ye-Xiong L. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomized, non-inferiority, open-label. The Lancet Oncology. 2019 Mar;20(3):352-360. https://doi:10.1016/S1470-2045(18)30813-110.1016/S1470-2045(18)30813-130711522
Search in Google Scholar Back to article
21. Schwartz GF, Cantor RI, Biermann WA. Neoadjuvant Chemotherapy Before Definitive Treatment for Stage III Carcinoma of the Breast. Archives of Surgery(Chicago, III:1960). 1987 Dec; 122(12):1430-1434. https://doi:10.1001/archsurg.1987.0140024007801410.1001/archsurg.1987.014002400780143689121
Search in Google Scholar Back to article

Challenges in Treatment and the Importance of Radiotherapy in a Synchronous Endometrial and Breast Cancer

Abstract

Paradigm

My account